MADRIGAL PHARMACEUTICALS, INC.

Pharmaceutical Preparations·WEST CONSHOHOCKEN, PA·FY end 12/31·CIK 1157601

Named Executive Officers

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
Bill SiboldPresident and Chief Executive Officer	$918.5K	$12.3M	$4.5M	$1.4M	$14.0K	$19.2M
David SoergelM.D. Executive Vice President and Chief Medical Officer	$418.2K	$5.9M	$2.2M	$659.1K	—	$9.2M
Rebecca TaubM.D. Senior Scientific and Medical Advisor and Former President, Research & Development and Chief Medical Officer	$617.5K	$4.1M	$1.5M	$604.5K	—	$6.9M
Mardi DierExecutive Vice President and Chief Financial Officer	$566.0K	$3.6M	$1.3M	$554.2K	$89.3K	$6.1M
Carole HuntsmanExecutive Vice President and Chief Commercial Officer	$540.3K	$3.2M	$1.2M	$529.0K	$9.8K	$5.4M
Shannon KelleyExecutive Vice President and Chief Legal Counsel	$535.2K	$3.0M	$1.1M	$523.9K	$14.0K	$5.2M

Bill Sibold · FY 2025

Stock awards$12.3M64%

Performance bonus$1.4M7%

Salary$918.5K5%

Other$4.6M24%

TSR % vs. CEO comp actually paid · 6 fiscal years · Item 402(v) disclosure

TSR

CEO comp

FY20

+22%

$6M

FY21

-24%

$1M

FY22

+161%

$38M

FY23

+108%

$42M

FY24

+178%

$31M

FY25

+424%

$84M

CEO total compMedian employeePay ratio (right axis)